Đánh giá tính hiệu quả chi phí của phương pháp thắt động mạch, thắt ống dẫn và thắt ống dẫn hỗ trợ bằng stent trong điều trị dị dạng mạch não chưa vỡ

Springer Science and Business Media LLC - Tập 33 Số 4 - Trang 1075-1086 - 2023
Lukas Goertz1, Julia Simões Corrêa Galendi2, Christoph Kabbasch1, Marc Schlamann1, Lenhard Pennig1, Matthias F. Froelich3, Marco Timmer4, Thomas Liebig5, Stephanie Stock2, Dirk Müeller2, Nils Große Hokamp1
1Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany
2Institute of Health Economics and Clinical Epidemiology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany
3Department of Radiology and Nuclear Medicine, University Medical Centre Mannheim, Mannheim, Germany
4Faculty of Medicine and University Hospital, Center for Neurosurgery, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany
5Faculty of Medicine and University Hospital, Department of Neuroradiology, University of Munich (LMU), Marchioninistraße 15, 81377, Munich, Germany

Tóm tắt

Tóm tắt Mục đích

Thông tin về chi phí và hiệu quả của một phương pháp điều trị cụ thể có liên quan đến việc ra quyết định và các nhà cung cấp dịch vụ y tế. Nghiên cứu này so sánh tính hiệu quả chi phí của Woven Endobridge (WEB) mới để điều trị dị dạng mạch não với phương pháp thắt ống dẫn thông thường và thắt ống dẫn hỗ trợ bằng stent (SAC) từ góc độ của Bảo hiểm Y tế bắt buộc tại Đức.

Phương pháp

Một mô hình mô phỏng mức độ bệnh nhân đã được xây dựng để mô phỏng bệnh nhân 55 tuổi có dị dạng động mạch não giữa không vỡ (kích thước: 3–11 mm) xem xét điều trị bằng WEB, thắt ống dẫn hoặc SAC về tỷ lệ mắc bệnh, kết quả chụp mạch, tái điều trị, chi phí thủ thuật và phục hồi chức năng, cũng như tỷ lệ vỡ. Tỷ lệ hiệu quả chi phí bổ sung (ICERs) được tính toán dưới dạng chi phí mỗi năm sống điều chỉnh chất lượng (QALYs) và chi phí mỗi năm không có tỷ lệ mắc bệnh thần kinh. Bất định được khám phá qua phân tích nhạy cảm xác định và xác suất. Phần lớn dữ liệu được thu thập từ các nghiên cứu đa trung tâm tiềm năng và phân tích tổng hợp của các nghiên cứu không ngẫu nhiên.

Từ khóa

#tính hiệu quả chi phí #Woven Endobridge #dị dạng mạch não chưa vỡ #thắt ống dẫn #thắt ống dẫn hỗ trợ bằng stent

Tài liệu tham khảo

Arzneimittelinformationen für Deutschland Stand: Januar 2022 (Arzneimittelinformationen), 1. Februar 2022 (Preise). https://www.rote-liste.de/. Accessed 17 February 2022

Ariyada K, Ohida T, Shibahashi K, Hoda H, Hanakawa K, Murao M. Long-term functional outcomes for world federation of neurosurgical societies grade V aneurysmal subarachnoid hemorrhage after active treatment. Neurol Med Chir. 2020;60:390–6.

Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford University Press; 2006.

Busse R, Blümel M, Knieps F, Bärnighausen T. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390:882–97.

Consortium YHE. Cost-effectiveness threshold. 2016. https://yhec.co.uk/glossary/cost-effectiveness-threshold/. Accessed 2 June 2022.

Cras TY, Hunink MM, Dammers R, van Es AC, Volovici V, Burke JF, Kremers FC, Dippel DW, Roozenbeek B. Surveillance of unruptured intracranial aneurysms: cost-effectiveness analysis for 3 countries. Neurology. 2022;99:e890–e903.

Dmytriw AA, Diestro JDB, Dibas M, Phan K, Sweid A, Cuellar-Saenz HH, Lay SV, Guenego A, Renieri L, Al Balushi A. International study of intracranial aneurysm treatment using Woven EndoBridge: results of the WorldWideWEB Consortium. Stroke. 2022;53:e47–e9.

Doble B, Pufulete M, Harris JM, Johnson T, Lasserson D, Reeves BC, Wordsworth S. Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study. Health Qual Life Outcomes. 2018;16:191.

Etminan N, Dörfler A, Steinmetz H. Unruptured intracranial aneurysms-pathogenesis and individualized management. Dtsch Ärztebl Int. 2020;117:235–42.

Ex P, Vogt V, Busse R, Henschke C. The reimbursement of new medical technologies in German inpatient care: What factors explain which hospitals receive innovation payments? Health Econ Policy Law. 2020;15:355–69.

Forman-Hoffman VL, Ault KL, Anderson WL, Weiner JM, Stevens A, Campbell VA, Armour BS. Disability status, mortality, and leading causes of death in the United States community population. Med Care. 2015;53:346–54.

Fukuda H, Sato D, Kato Y, Tsuruta W, Katsumata M, Hosoo H, Matsumaru Y, Yamamoto T. Comparing retreatments and expenditures in flow diversion versus coiling for unruptured Intracranial aneurysm treatment: a retrospective cohort study using a real-world national database. Neurosurgery. 2020;87:63–70.

Funakoshi Y, Imamura H, Tani S, Adachi H, Fukumitsu R, Sunohara T, Omura Y, Matsui Y, Sasaki N, Fukuda T, Akiyama R, Horiuchi K, Kajiura S, Shigeyasu M, Iihara K, Sakai N. Predictors of cerebral aneurysm rupture after coil embolization: single-center experience with recanalized aneurysms. AJNR Am J Neuroradiol. 2020;41:828–35.

García Rodríguez LA, Martín-Pérez M, Hennekens CH, Rothwell PM, Lanas A. Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies. PLoS ONE. 2016;11:e160046.

Gesundheitswesen IfQuWi. General methods for the assessment of the relation of benefits to costs. 2015.

Goyal N, Hoit D, DiNitto J, Elijovich L, Fiorella D, Pierot L, Lamin S, Spelle L, Saatci I, Cekirge S. How to WEB: a practical review of methodology for the use of the Woven EndoBridge. J NeuroIntervent Surg. 2020;12:512–20.

Greving JP, Wermer MJ, Brown RD Jr., Morita A, Juvela S, Yonekura M, Ishibashi T, Torner JC, Nakayama T, Rinkel GJ, Algra A. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13:59–66.

Grochtdreis T, Dams J, König HH, Konnopka A. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ. 2019;20:933–44.

Hetts S, Turk A, English J, Dowd C, Mocco J, Prestigiacomo C, Nesbit G, Ge S, Jin J, Carroll K. Stent-assisted coiling versus coiling alone in unruptured intracranial aneurysms in the matrix and platinum science trial: safety, efficacy, and mid-term outcomes. AJNR Am J Neuroradiol. 2014;35:698–705.

Huhtakangas J, Lehto H, Seppä K, Kivisaari R, Niemelä M, Hernesniemi J, Lehecka M. Long-term excess mortality after aneurysmal subarachnoid hemorrhage: patients with multiple aneurysms at risk. Stroke. 2015;46:1813–8.

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Allgemeine Methoden Version 6.1 vom 24.01.2022. 2022. https://www.iqwig.de/methoden/allgemeine-methoden-v6-1.pdf. Accessed 11 Feb 2022.

Kabbasch C, Goertz L, Siebert E, Herzberg M, Hamisch C, Mpotsaris A, Dorn F, Liebig T. Treatment strategies for recurrent and residual aneurysms after Woven Endobridge implantation. J NeuroIntervent Surg. 2019;11:390–5.

Kashkoush A, El-Abtah ME, Srivatsa S, Desai A, Davison M, Achey R, Mahapatra A, Patterson T, Moore N, Bain M. Comparative effectiveness of stent-assisted coiling and Woven EndoBridge embolization for the treatment of unruptured wide-neck bifurcation intracranial aneurysms. JNS. 2022;1:1–7.

King JT Jr., Brandt CA, Tsevat J, Roberts MS. A national internet-based survey of cerebral aneurysm preference-based quality of life. Neurosurgery. 2009;64:249–54. discussion 254–245.

Intitut für Entgeltsysteme im Krankenhaus DRG-System. http://www.g-drg.de/cms. Accessed 14 September 2022

Lecler A, Raymond J, Rodriguez-Régent C, Al Shareef F, Trystram D, Godon-Hardy S, Hassen BW, Meder JF, Oppenheim C, Naggara ON. Intracranial aneurysms: recurrences more than 10 years after endovascular treatment—a prospective cohort study, systematic review, and meta-analysis. Radiology. 2015;277:173–80.

McGauran N, Wieseler B, Kreis J, Schüler Y‑B, Kölsch H, Kaiser T. Reporting bias in medical research—a narrative review. Trials. 2010;11:1–15.

Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis. 2002;11:304–14.

Munich SA, Cress MC, Rangel-Castilla L, Sonig A, Ogilvy CS, Lanzino G, Petr O, Mocco J, Morone PJ, Snyder KV. Neck remnants and the risk of aneurysm rupture after endovascular treatment with coiling or stent-assisted coiling: much ado about nothing? Neurosurgery. 2019;84:421–7.

Phan K, Huo YR, Jia F, Phan S, Rao PJ, Mobbs RJ, Mortimer AM. Meta-analysis of stent-assisted coiling versus coiling-only for the treatment of intracranial aneurysms. J Clin Neurosci. 2016;31:15–22.

Pierot L, Moret J, Barreau X, Szikora I, Herbreteau D, Turjman F, Holtmannspotter M, Januel AC, Costalat V, Fiehler J, Klisch J, Gauvrit JY, Weber W, Desal H, Velasco S, Liebig T, Stockx L, Berkefeld J, Molyneux A, Byrne J, Spelle L. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg. 2018;10:553–9.

Rai AT, Turner RC, Brotman RG, Boo S. Comparison of operating room variables, radiation exposure and implant costs for WEB versus stent assisted coiling for treatment of wide neck bifurcation aneurysms. Interv Neuroradiol. 2021;27:465–72.

Rebchuk AD, O’Neill ZR, Szefer EK, Hill MD, Field TS. Health utility weighting of the modified rankin scale: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e203767.

Ridwan S, Urbach H, Greschus S, Hagen JV, Esche J, Boström A. Health economic aspects of aneurysmal subarachnoid hemorrhage: factors determining first year in-hospital treatment expenses. J Neurol Surg A Cent Eur Neurosurg. 2021;82:204–10.

Ridwan S, Urbach H, Greschus S, von Hagen J, Esche J, Boström A. Health care costs of spontaneous aneurysmal subarachnoid hemorrhage for rehabilitation, home care, and in-hospital treatment for the first year. World Neurosurg. 2017;97:495–500.

Schad M, John J. Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis. Eur J Health Econ. 2012;13:127–44.

Tan SS, Geissler A, Serdén L, Heurgren M, Van Ineveld BM, Redekop WK, Roijen H‑vL. DRG systems in Europe: variations in cost accounting systems among 12 countries. Eur J Public Health. 2014; 1023–8. https://doi.org/10.1093/eurpub/cku025.

Teleb MS, Pandya DJ, Castonguay AC, Eckardt G, Sweis R, Lazzaro MA, Issa MA, Fitzsimmons BF, Lynch JR, Zaidat OO. Safety and predictors of aneurysm retreatment for remnant intracranial aneurysm after initial endovascular embolization. J Neurointerv Surg. 2014;6:490–4.

Thompson BG, Brown RD Jr., Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES Jr., Duckwiler GR, Harris CC, Howard VJ, Johnston SC, Meyers PM, Molyneux A, Ogilvy CS, Ringer AJ, Torner J. Guidelines for the management of patients with unruptured Intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2368–400.

Tureli D, Sabet S, Senol S, Andac N, Donmez H, Geyik S, Baltacioglu F, Cekirge S. Stent-assisted coil embolization of challenging intracranial aneurysms: initial and mid-term results with low-profile ACCLINO devices. Acta Neurochir. 2016;158:1545–53.

Vemer P, Corro Ramos I, Van Voorn G, Al M, Feenstra T. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016;34:349–61.

Walendy V, Stang A. Clinical management of unruptured intracranial aneurysm in Germany: a nationwide observational study over a 5-year period (2005–2009). BMJ Open. 2017;7:e12294.

Walendy V, Strauss C, Rachinger J, Stang A. Treatment of aneurysmal subarachnoid haemorrhage in Germany: a nationwide analysis of the years 2005–2009. Neuroepidemiology. 2014;42:90–7.

Zhang SM, Liu LX, Ren PW, Xie XD, Miao J. Effectiveness, safety and risk factors of woven endobridge device in the treatment of wide-neck Intracranial aneurysms: systematic review and meta-analysis. World Neurosurg. 2020;136:e1–e23.